Enews from the Alzheimer's Association

Having trouble viewing this message? You may view it as a web page. You may also view e-news archives.
To prevent mailbox filters from deleting your Alzheimer's Association email communications, please add alzheimers_enews@alz.org to your address book.
July 25, 2018
24/7 Helpline: 800.272.3900
Treating high blood pressure may reduce dementia risk
Nearly 6,000 leading researchers, clinicians, investigators and care providers from 68 countries are meeting this week at the Alzheimer's Association International Conference® 2018 (AAIC®), the world's largest forum for the dementia research community, to share the latest study results, theories and discoveries. Results presented from the federally funded SPRINT MIND Study showed significant reductions in the risk of mild cognitive impairment (MCI) and the combination of MCI and dementia through aggressive lowering of systolic blood pressure.

Click here to read more
Pregnancy and reproductive history may be linked to dementia
Research from AAIC highlighted gender differences associated with dementia and Alzheimer's, including the first-ever large-scale study of reproductive history and dementia risk in women. The results suggested a link between dementia risk and number of children, number of miscarriages, age at first menstrual period and length of reproductive period. Separate research found a correlation between cumulative months of pregnancy and Alzheimer's risk.
Click here to read more
Online Tools
Your Local Community
 
Results of Alzheimer's drug study show promise
Today at AAIC, Eisai Co., Ltd and Biogen Inc. announced additional results of a Phase II clinical trial of a drug called BAN2401. Although the primary results of the study at 12 months were negative in December 2017, researchers reported positive results at 18 months on several secondary outcomes, including reduction of amyloid plaques and improvement of cognition and function. A larger confirmatory trial is needed.
Click here to read more
Your donations and support make a difference.
More Resources: 
Behaviors  | 
The Alzheimer's Association is the leading voluntary health organization in Alzheimer's care, support and research. Our mission is to eliminate Alzheimer's disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health.

Alzheimer's Association National Office 225 N. Michigan Ave., Fl. 17, Chicago, IL 60601
© 2018 Alzheimer's Association. All rights reserved. www.alz.org | 800.272.3900
To change your email preferences click here.